Detail akcie BioPharma Cred USD online

Business Summary: BioPharma Credit PLC is a United Kingdom-based closed-ended investment company. The Company is a specialist debt investor in the life sciences industry. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. It seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. The Company may also invest in equity issued by a life sciences company, acquired directly from the life sciences company or in the secondary market. It will seek to create a diversified portfolio of investments by investing across a range of different forms of debt assets issued by a variety of borrowers. It has two wholly owned subsidiaries: BPCR Limited Partnership and BPCR GP Limited. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Biopharma Credit PLC revenues increased 6% to $83.8M. Net income increased 1% to $72.8M. Revenues reflect Change in unrealised (losses)/gains increase from -$4.8M to $7.5M. Net income was partially offset by Other expenses increase of 10% to $266K (expense), Legal & professional fees increase of 23% to $116K (expense), Directors fees increase of 5% to $290K (expense).